Last Price
0.129
Today's Change
-0.001 (0.76%)
Day's Change
0.117 - 0.129
Trading Volume
3,062,019
Market Cap
10 Million
Shares Outstanding
79 Million
Avg Volume
17,221,233
Avg Price (50 Days)
0.36
Avg Price (200 Days)
1.02
PE Ratio
-4.30
EPS
-0.03
Earnings Announcement
11-Nov-2024
Previous Close
0.13
Open
0.12
Day's Range
0.1211 - 0.129
Year Range
0.101 - 17.17
Trading Volume
3,062,019
1 Day Change
-0.77%
5 Day Change
1.42%
1 Month Change
-16.23%
3 Month Change
-79.10%
6 Month Change
-87.35%
Ytd Change
-76.54%
1 Year Change
-98.78%
3 Year Change
-98.60%
5 Year Change
-98.60%
10 Year Change
-98.60%
Max Change
-98.60%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
AEON Biopharma, Inc., a biopharmaceutical company, focuses on the development botulinum toxins for the treatment of debilitating medical conditions. It also develops 900 kDabotulinum toxin complex, ABP-450, for migraine, cervical dystonia, and gastroparesis. The company was formerly known as ALPHAEON Corporation and changed its name to AEON Biopharma, Inc. in December 2019. AEON Biopharma, Inc. was incorporated in 2012 and is headquartered in Newport Beach, California.